MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 222 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,759,315 | -37.6% | 86,302 | -35.1% | 0.68% | -42.0% |
| Q4 2022 | $6,026,230 | -62.7% | 133,000 | +33.0% | 1.18% | -65.1% |
| Q2 2021 | $16,153,000 | -30.2% | 100,000 | -25.9% | 3.39% | -29.1% |
| Q1 2021 | $23,126,000 | -61.7% | 135,000 | -82.6% | 4.78% | -13.8% |
| Q3 2019 | $60,380,000 | -99.9% | 775,000 | 0.0% | 5.55% | -37.4% |
| Q2 2019 | $79,825,000,000 | +1930838.6% | 775,000 | -10.9% | 8.86% | +943.7% |
| Q4 2016 | $4,134,000 | +174.7% | 870,261 | +282.3% | 0.85% | +121.1% |
| Q3 2016 | $1,505,000 | – | 227,657 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |